Have you already had a breakthrough COVID infection? Penn In the News The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite. Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Penn In the News Philadelphia Inquirer Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Frederic Bushman of the Perelman School of Medicine spoke about new COVID-19 variants and said his team has not yet seen the “delta-plus” or lambda variants in the Philadelphia-area samples they’ve analyzed. COVID-19 transmission rates move into substantial range across majority of tri-state region Penn In the News CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases Penn In the News WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Penn In the News Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Study finds that higher death rates for Black COVID patients tied to hospital quality Penn In the News 6ABC.com Study finds that higher death rates for Black COVID patients tied to hospital quality David Asch of the Perelman School of Medicine and the Wharton School spoke about his research on racial disparities in health outcomes for hospitalized COVID-19 patients. "Perhaps the main reason that Black patients tend to have worse outcomes than white patients is because they go to hospitals that provide worse care for all," he said. "I think it's a story of racial residential segregation. Most people go to hospitals near where they live. And we fund hospitals very much by local resources." The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. Load More
Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots.
Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite.
Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Penn In the News Philadelphia Inquirer Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Frederic Bushman of the Perelman School of Medicine spoke about new COVID-19 variants and said his team has not yet seen the “delta-plus” or lambda variants in the Philadelphia-area samples they’ve analyzed. COVID-19 transmission rates move into substantial range across majority of tri-state region Penn In the News CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases Penn In the News WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Penn In the News Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Study finds that higher death rates for Black COVID patients tied to hospital quality Penn In the News 6ABC.com Study finds that higher death rates for Black COVID patients tied to hospital quality David Asch of the Perelman School of Medicine and the Wharton School spoke about his research on racial disparities in health outcomes for hospitalized COVID-19 patients. "Perhaps the main reason that Black patients tend to have worse outcomes than white patients is because they go to hospitals that provide worse care for all," he said. "I think it's a story of racial residential segregation. Most people go to hospitals near where they live. And we fund hospitals very much by local resources." The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. Load More
COVID-19 transmission rates move into substantial range across majority of tri-state region Penn In the News CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases Penn In the News WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Penn In the News Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Study finds that higher death rates for Black COVID patients tied to hospital quality Penn In the News 6ABC.com Study finds that higher death rates for Black COVID patients tied to hospital quality David Asch of the Perelman School of Medicine and the Wharton School spoke about his research on racial disparities in health outcomes for hospitalized COVID-19 patients. "Perhaps the main reason that Black patients tend to have worse outcomes than white patients is because they go to hospitals that provide worse care for all," he said. "I think it's a story of racial residential segregation. Most people go to hospitals near where they live. And we fund hospitals very much by local resources." The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. Load More
Penn researching ways to avoid side effects of key treatment for serious COVID cases Penn In the News WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Penn In the News Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Study finds that higher death rates for Black COVID patients tied to hospital quality Penn In the News 6ABC.com Study finds that higher death rates for Black COVID patients tied to hospital quality David Asch of the Perelman School of Medicine and the Wharton School spoke about his research on racial disparities in health outcomes for hospitalized COVID-19 patients. "Perhaps the main reason that Black patients tend to have worse outcomes than white patients is because they go to hospitals that provide worse care for all," he said. "I think it's a story of racial residential segregation. Most people go to hospitals near where they live. And we fund hospitals very much by local resources." The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. Load More
A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential.
There are few good COVID antivirals, but that could be changing Penn In the News Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Study finds that higher death rates for Black COVID patients tied to hospital quality Penn In the News 6ABC.com Study finds that higher death rates for Black COVID patients tied to hospital quality David Asch of the Perelman School of Medicine and the Wharton School spoke about his research on racial disparities in health outcomes for hospitalized COVID-19 patients. "Perhaps the main reason that Black patients tend to have worse outcomes than white patients is because they go to hospitals that provide worse care for all," he said. "I think it's a story of racial residential segregation. Most people go to hospitals near where they live. And we fund hospitals very much by local resources." The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. Load More
Study finds that higher death rates for Black COVID patients tied to hospital quality Penn In the News 6ABC.com Study finds that higher death rates for Black COVID patients tied to hospital quality David Asch of the Perelman School of Medicine and the Wharton School spoke about his research on racial disparities in health outcomes for hospitalized COVID-19 patients. "Perhaps the main reason that Black patients tend to have worse outcomes than white patients is because they go to hospitals that provide worse care for all," he said. "I think it's a story of racial residential segregation. Most people go to hospitals near where they live. And we fund hospitals very much by local resources." The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines.
The long view on COVID-19 vaccine safety and efficacy A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID) The long view on COVID-19 vaccine safety and efficacy Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines.